Sterne Kessler’s Jacqueline Wright Bonilla was featured in World IP Review for her recent hire at the firm as a director in the Biotechnology & Chemical and Trial & Appellate Practice Groups.

Bonilla brings to the firm over a decade of experience at the PTAB, as well as her service in a variety of senior positions at the U.S. Patent and Trademark Office (USPTO), including Senior Legal Advisor to the USPTO Director and Acting Director for the USPTO’s Central Reexamination Unit (CRU).

At the firm, Bonilla will focus on life sciences patent litigation and pre-litigation matters, including advising on PTAB challenges and policy, ex parte reexaminations, complex patent interferences, ITC proceedings, and federal district court and appellate litigation.

“Sterne Kessler’s reputation as a leader in all aspects of IP litigation and USPTO practice, including complex matters before the PTAB and CRU, is second to none, and I’m truly excited to be a part of this exceptional team,” said Bonilla. “Having seen firsthand the firm’s top-tier advocacy and innovative thinking, I look forward to contributing my experience and collaborating with my new colleagues to deliver creative strategies that drive real impact for our clients.”

Bonilla’s arrival to the firm has been covered in Law360, The National Law Journal, POLITICO, and Bloomberg Law.